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Abstract
Background: Klebsiella pneumoniae is a gram-negative bacterial species capable of occupying a broad range of
environmental and clinical habitats. Known as an opportunistic pathogen, it has recently become a major causative
agent of clinical infections worldwide. Despite growing knowledge about the highly diverse population of K.
pneumoniae, the evolution and clinical significance of environmental K. pneumoniae, as well as the relationship
between clinical and environmental K. pneumoniae, are poorly defined.
Methods: We isolated and sequenced K. pneumoniae from in-patients in a single hospital in Thailand, as well as
hospital sewage, and surrounding canals and farms within a 20-km radius.
Results: Phylogenetic analysis of 77 K. pneumoniae (48 clinical and 29 non-clinical isolates) demonstrated that the
two groups were intermixed throughout the tree and in some cases resided in the same clade, suggesting recent
divergence from a common ancestor. Phylogenetic comparison of the 77 Thai genomes with 286 K. pneumoniae
from a global collection showed that Thai isolates were closely related to the clinical sub-population of the global
collection, indicating that Thai clinical isolates belonged to globally circulating lineages. Dating of four Thai K.
pneumoniae clades indicated that they emerged between 50 and 150 years ago. Despite their phylogenetic
relatedness, virulence factors and β-lactamase resistance genes were more numerous in clinical than in environmental
isolates. Our results indicate that clinical and environmental K. pneumoniae are closely related, but that hospitals may
select for isolates with a more resistant and virulent genotype.
Conclusions: These findings highlight the clinical relevance of environmental K. pneumoniae isolates.
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Background
Klebsiella pneumoniae is a clinically important gram-
negative bacterium associated with opportunistic infection
in patients with a compromised immune system or receiv-
ing other forms of complex medical care [1–3]. This
species is disseminated in healthcare settings via person-
to-person contact, medical equipment, and contaminated
environments [2, 3]. The emergence of multidrug-
resistant K. pneumoniae is becoming an increasingly
serious issue for clinical practice, largely related at the
present time to isolates that express extended-spectrum
β-lactamase (ESBL) enzymes that hydrolyze a broad
spectrum of β-lactams [4, 5]. This is compounded by
the emergence of K. pneumoniae that express carbape-
nemases such as KPC-type β-lactamase [5–7] and the
recent detection of colistin-resistant K. pneumoniae
due to the presence of the mcr-1 gene [8]. These resist-
ance genes are carried on mobile genetic elements that
facilitate their spread within and between bacterial
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species, a process that is likely to result in a rise in the
number of K. pneumoniae infections that are very difficult
to treat. Furthermore, multidrug-resistant K. pneumoniae
are associated with nosocomial outbreaks, particularly
in high prevalence countries including those in East
Asia [9, 10].
Beyond healthcare settings and hospital patients, K.
pneumoniae is ubiquitous in nature and occupies a di-
verse range of niches. These include environmental
sources, such as soil and wastewater, mucosal surfaces
and the gut of humans and animals, and food sources,
such as meat [11]. Environmental K. pneumoniae is less
well studied than isolate collections associated with clin-
ical disease. Some studies have shown that K. pneumo-
niae of environmental origin are highly similar to
clinical isolates with regards to phenotypic and some
genetic features [12–14], but others have reported differ-
ences in virulence characteristics between the two
groups [15, 16]. The parallel evolution of K. pneumoniae
and putative acquisition of antimicrobial resistance de-
terminants and virulence factors in healthcare settings
and the environment have led non-clinical habitats to be
considered as potential reservoirs for hyper-virulent and
hyper-resistant K. pneumoniae [15], although evidence to
support the potential clinical importance of non-clinical
K. pneumoniae is inconclusive. A recent study of the clin-
ical relevance of meat-source K. pneumoniae showed dif-
ferences in antibiotic resistance but similar virulence
characteristics for isolates from retail meat and those asso-
ciated with urinary tract infections in humans [16].
Here, we report the findings of an in-depth compari-
son of the evolution and epidemiology of ESBL-positive
K. pneumoniae using a One Health approach [17, 18].
We utilized the fine-scale resolution of whole genome
sequencing to investigate genetic relatedness, antimicro-
bial resistance, and the presence of genes encoding viru-
lence determinants in an unbiased, prospective
collection of K. pneumoniae from patients in one hos-
pital, as well as from environmental water, hospital sew-
age, and farm waste in the proximity of the hospital.
These genomes were placed into a global context
through a comparison with isolates recovered from vari-
ous clinical and non-clinical sources worldwide [19].
Our results highlight the clinical relevance of environ-
mental K. pneumoniae isolates, and demonstrate that
environmental and clinical K. pneumoniae are highly re-
lated but that hospitals select for K. pneumoniae with a
more antimicrobial-resistant and virulent genotype.
Methods
Study design and bacterial isolates
The bacterial collection consisted of 77 ESBL-producing
K. pneumoniae isolated between 2014 and 2015. Clinical
isolates (n = 48) were obtained from consecutive patients
with positive samples processed by the diagnostic micro-
biology laboratory at Bhuddhasothorn Hospital, Cha-
choengsao, Bangkok, Thailand between December 2014
and April 2015. Data were collected on date of isolation
and sample type, and samples were de-duplicated so that
only one isolate per patient was included. Speciation and
ESBL positivity were initially determined using Standard
Operating Procedures supplied by the Department of
Medical Science, Ministry of Public Heath, Thailand
and Clinical and Laboratory Standards Institute (CLSI)
guidelines (M100-S24 and M100-S25), respectively. The
species was subsequently confirmed using matrix-
assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS; Biotyper version 3.1,
Bruker Daltonics, Coventry, UK). Antimicrobial suscep-
tibility testing was repeated using the N206 card on the
Vitek 2 instrument (bioMérieux, Marcy l’Étoile, France)
calibrated against EUCAST breakpoints, and these re-
sults were used during the analysis.
Environmental and livestock-associated isolates (n = 29)
were obtained through a cross-sectional survey between
January 2015 and February 2015. Wastewater samples
were collected from 27 canals and 11 farms within a 20-
km radius of Bhuddhasothorn Hospital. The farms reared
pigs (n = 2), chickens (n = 6), ducks (n = 2), and both
chickens and ducks (n = 1). Samples were collected from
wastewater collection areas (commonly concrete gullies
that drained waste from animal housing). The longitude
and latitude of each sampling site were recorded using
GPSMAP 60CSx (Garmin, Taiwan). A further two waste-
water samples were taken from the Bhuddhasothorn
Hospital wastewater treatment system (one pre-treatment
and one post-treatment water sample). At each site, grab
samples of 0.5 L each were collected into sterile bottles
containing 9 mg of sodium thiosulfate pentahydrate
(Merck, Darmstadt, Germany). All samples were trans-
ported to the laboratory on ice packs in the dark and
processed within 12 h.
One mL of triplicate serial 10-fold dilutions of wastewa-
ter samples were concentrated using the filtration tech-
nique onto 0.45-μm pore size filter membranes (Merck,
Darmstadt, Germany). Membranes were then placed onto
the surface of ESBL Brilliance agar (Oxoid, Basingstoke,
UK) and incubated for 48 h at 35 °C in air. For each sam-
pling site, up to 10 colonies suspected to be K. pneumo-
niae based on color (green) were picked and the presence
of ESBL confirmed using the combination disc test
(M100-S24 and M100-S25). Escherichia coli ATCC25922
and K. pneumoniae ATCC700603 were used as negative
and positive controls, respectively. Positive colonies were
speciated using MALDI-TOF MS, and antimicrobial
susceptibility testing of confirmed K. pneumoniae was
determined using the N206 card as described above. All
isolates were stored at −80 °C until further analysis.
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Whole genome sequencing and pan-genome analysis
DNA extraction, sequencing, and assembly of reads
were performed as previously described [20]. Sequen-
cing was performed on an Illumina HiSeq2000. Details
of reads, depth of coverage, and N50 are provided in
Additional file 1. The sequence reads were submitted to
the European Nucleotide Archive (ENA) under acces-
sion numbers [ENA:ERP012787 and ENA:PRJEB11403].
An average coverage of 85-fold was achieved. Genomes
were assembled using Velvet [21] with the pipeline and
improvements found at https://github.com/sanger-
pathogens/vr-codebase and https://github.com/sanger-
pathogens/assembly_improvement. The de novo assem-
blies were annotated using Prokka [22], and sequence
types (STs) were identified from the sequence data using a
multilocus sequence typing (MLST) database (http://
bigsdb.pasteur.fr/klebsiella/) and an in-house script
(https://github.com/sanger-pathogens/mlst_check).
Phylogenetic analysis and substitution rate calculation
Study genomes were contextualized against a global
collection. Sequence data for 286K. pneumoniae isolates
reported previously [19] were downloaded from the ENA
and combined with the 77 study genomes. As in our
study, these isolates were also sequenced on a HiSeq se-
quencing system. Short reads for the 363 isolates were
mapped against the reference genome K. pneumoniae
Ecl8 (accession number: HF536482 CANH01000000)
using SMALT v0.7.4 (http://www.sanger.ac.uk/science/
tools/smalt-0). An in-house tool that combined SAMtools
mpileup [23] and BCFtools, as detailed in [24], was used
to annotate single nucleotide polymorphisms (SNPs), after
which the pairwise SNP distances were calculated from
the multiple alignment to obtain the phylogenetic tree.
Mapping each genome to the reference genome allowed
us to identify genes that were conserved in the core gen-
ome of the study isolates and reference genome. We con-
structed a maximum likelihood tree using FastTree
version 2.1.3 with 100 bootstraps and a midpoint root
[25]. We employed FigTree (http://tree.bio.ed.ac.uk/soft-
ware/figtree/), Microreact (www.microreact.org), and in-
house tools to visualize the results.
To determine the substitution rate for each clade (see
the Results section for more details), reads were first
mapped within each clade to the sequence obtained after
concatenating contigs for the isolate with the best con-
tigs statistics, i.e., the isolate with the highest N50 value.
After mapping the reads to the new references, high-
density SNP regions (which are indicative of putative re-
combination events) were removed from the multiple
alignments using Gubbins, which works best for closely
related isolates and detects high SNP density regions
based on a significantly higher number of variable sites
in a sliding window across the genome compared to the
rest of the genome [26]. The significance of the temporal
signal was assessed according the R-squared value obtained
from the root-to-tip distance versus time of isolation plot.
We generated 10,000 sample sets by bootstrapping and
assessed the value of R-squared against the distribution of
R-squared values. Of four clades we identified on the
phylogenetic tree of the Thai and global isolates, we found
strong signals (>99%) for clades 1 and 3, after leaving one
isolate out from either clade. BEAST version 1.7 was used to
estimate the substitution rate and date the phylogenetic tree
for the clades with significant temporal signal [27], using a
strict molecular clock and a lognormal and uniform prior
distribution models for base frequencies with constant
population size. Three chains of BEAST were run for 50
million generations (sampling every 10 generations) and
checked as to whether the runs had converged on similar
values. Convergence was controlled using effective sample
size (ESS) value (we considered a cut-off of 200 ESS for
convergence). We excluded 10 million initial steps as a
burn-in phase and merged the out trees with the Tree-
Annotator program in the BEAST package, and chose the
model in which convergence always occurred (for the clades
we tested here, the strict molecular clock with a uniform
prior distribution for base frequencies always converged).
Identification of antimicrobial resistance determinants,
virulence factors, and plasmids
We employed the srst2 package [28], which takes short
reads and maps them to reference sequences, to find anti-
biotic resistance genes, virulence factors, and plasmid
replicons. The sequences for 79 virulence genes were
obtained from the Pasteur institute data repository (http://
bigsdb.web.pasteur.fr/klebsiella/klebsiella.html, http://bigs
db.pasteur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_
seqdef_public&page=downloadAlleles). An in-house tool
was used to visualize the results. To find the possible con-
text of the virulence (i.e., chromosomal or plasmid based),
we first found the contig in which the virulence factor was
located and then extracted the 5-kb sequences upstream
and downstream of the gene; if this exceeded the contig
size, we considered the end and start of the contig. We
then performed blast searches using the NCBI non-
redundant nucleotide database to find out whether the hit
sequences corresponded to a chromosomal or a plasmid
region. Furthermore, we assessed the significance between
the presence of virulence factors in the clinical/environ-
mental sub-populations by performing logistic regression.
To this end, we took the presence/absence of individual
genes as the categorical predictor parameter and the en-
vironmental/clinical status as the categorical dependent
variable. Significance of association (p value < 0.05) was
then assessed by considering the z-statistic, which is the
regression coefficient divided by its standard error and has
a standard normal distribution.
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Results
A One Health approach was taken for the sampling and
isolation of ESBL-positive K. pneumoniae from clinical
samples in a hospital in Thailand, together with hospital
sewage, environmental (canal) water, and wastewater
from farms within a 20-km radius of the hospital. A
phylogenetic tree of the whole genomes of the 77 K.
pneumoniae isolates (48 clinical and 29 environmental,
of which 24 were from canals, 3 from farms, and 2 from
untreated hospital sewage) revealed a diverse population
containing three major lineages, one of which contained
the majority of isolates (Fig. 1). Several minor clades
were also apparent, some of which showed evidence of
recent expansion (Fig. 1). Clinical and environmental
isolates were intermixed throughout the tree and in
some cases resided in the same clade, suggesting recent
divergence from a common ancestor (Fig. 1). The 3 iso-
lates of farm origin were distributed across the tree, and
clustered with canal and clinical isolates or with canal
isolates alone (Fig. 1). High genetic diversity was also
reflected by the number of STs (n = 38) to which the 77
isolates were assigned. This included STs that have been
isolated elsewhere in the world. For example, ST35,
ST307, and ST16 were recently recovered from clinical
settings in France, the USA, and the Netherlands, re-
spectively [29–31]. Mapping the geographical distribu-
tion of isolates recovered from the environment
demonstrated that isolates from the same sampling site
were frequently very genetically diverse (Fig. 1).
To further characterize the 77 study genomes, we
combined them with genomes for a global collection of
286 K. pneumoniae complex isolates [19]. The resulting
phylogenetic tree revealed that Thai isolates were dis-
persed across the combined population. Isolates in the
global collection had been defined previously based on
phylogroup, and Thai isolates were observed to cluster
in phylogroups KpI, KpIIa, and KpIIb, with the majority
residing in KpI (Fig. 2a). This broader genetic context
highlighted the presence of several clades of Thai iso-
lates; those containing at least 4 Thai isolates (clades 1
to 4) were subjected to more detailed analysis to uncover
their recent evolutionary history. These clades included
30 of the 77 total isolates. A strong temporal signal was
found for clade 1 and clade 3 after removing regions of
recombination. This allowed us to estimate the substitu-
tion rates, which were 8.33 × 10−7 (95% confidence
Hospital
Farm
Wastewater
Canals
Key
50000 SNPs
Fig. 1 Map showing the geographical origin of study isolates. The triangle denotes Bhuddhasothorn Hospital and the maximum likelihood tree
for 77 K. pneumoniae isolates from clinical and environmental samples (canals, livestock, and hospital sewage) showing the distribution of STs
across the population. Triangle and circles correspond to clinical and environmental isolates, respectively. Wastewater isolates were recovered from
the hospital and therefore have the same location as the hospital in the map. An interactive map can be found at www.microreact.org/project/
Skog9F1ex
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interval [CI]: 6.23 × 10−7, 1.05 × 10−6) per site per year
for clade 1 and 3.78 × 10−7 (95% CI: 7.47 × 10−8, 7.54 ×
10−7) per site per year for clade 3. The most recent com-
mon ancestor (MRCA) for clades 1 and 3 was estimated
to exist 50 to 70 years ago (Fig. 2b). Using the average
substitution rates for clades 1 and 3, we also estimated
the age of the MRCA for clades 2 and 4 to be 150 and
50 years ago, respectively (Fig. 2b). We conclude that ex-
pansion of these K. pneumoniae clones has taken place
over the past few decades.
Thai isolates residing in clades 1 and 3 were inter-
mixed with isolates from other countries in the global
collection (Fig. 3). The Thai isolates in clade 1 fell into
two sub-clades of clinical origin, both of which were es-
timated to have emerged in the past few decades. These
were more distantly related to two clinical isolates from
community and nosocomial infection in the global col-
lection (Fig. 3). Clade 3 also contained two Thai sub-
clades, one of which was composed of clinical isolates.
The second sub-clade consisted largely of environmental
isolates but had recently diverged from a clinical Thai
isolate (Fig. 3). Global isolates in clade 3 were of hospital
origin and nosocomial infections.
To generalize our findings about the epidemiological
links between global and clinical and environmental Thai
isolates for the isolates not included in clades 1 or 3, we
excluded the isolates in the two clades and then used the
average substitution rates for isolates in clades 1 and 3 to
estimate divergence times between a Thai isolate and any
other Thai or global isolate that was less than 250 SNPs
apart (this corresponds to approximately 50 years, which
is the age of the MRCA of clade 3, which is older than
clade 1). This revealed that Thai isolates appeared to have
diverged more recently from each other than from the
global isolates (Fig. 4). The majority of recent divergences
in the Thai collection occurred between isolates from the
same origin of isolation, i.e., environment or hospital
(17 out of 24). However, there were several cases of re-
cent divergence involving isolates of both environmen-
tal and hospital origin, as well as evidence for recent
divergence between isolates from different environmen-
tal origins, i.e., different canals (Fig. 4). Moreover, one
putative transmission event may have occurred between
isolates of canal and farm origin (Fig. 4). The Thai iso-
lates involved in 25 recent divergence events between a
Thai and global isolates were all of clinical origin, and
15 and 7 of these isolates were recovered from invasive
and non-invasive infections, respectively (Fig. 3). Fur-
thermore, 19 out of 25 cases occurred between ST23
isolates, a well-known hyper-virulent strain. Taken to-
gether, these findings indicate that K. pneumoniae has
rapidly expanded within the environment and hospitals,
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KpI
KpIIa
KpIIb
KpIII
30000 SNPs
Thailand
Australia
UK
Indonesia
Laos
Singapore
USA
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Key
a
b
Fig. 2 a Phylogenetic tree of the 77 Thai isolates placed in the context of a global collection. Each color corresponds to a country. Shaded clades
refer to those described in the text. b Dating the most recent common ancestor for clades identified on the phylogenetic tree. To calculate the
mean and upper and lower bounds of age root for clades 1 and 3, which lacked a temporal signal, we divided the root-to-tip distances of the
root by mean substitution rates (and upper and lower bounds for 95% confidence interval) of clades 1 and 3
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and that in some instances, isolates of different origins
have only recently diverged. Furthermore, Thai isolates
were closely related to the clinical sub-population of
the global collection, suggesting that the clinical collec-
tion is a part of a global circulation of hyper-virulent K.
pneumoniae (Fig. 3).
We then investigated the distribution of plasmid repli-
cons and virulence factors in the Thai isolates. The pre-
dominant plasmid replicons were KpN3 and ColMG828
and less frequently the R plasmid, all of which are
known to carry multiple resistance and virulence genes
(Additional file 2: Figure S1). The majority of the global
K. pneumoniae isolates also harbored these plasmid
replicons (results not shown), indicating their global dis-
tribution. These replicons were present in isolates from
both the environment and clinical samples (Additional
file 2: Figure S1). Of the 75 virulence factors considered,
10 were present in >95% of isolates, examples being the
mrk genes encoding fimbrial biosynthesis proteins and
iutA encoding ferric aerobactin receptor [32]. By con-
trast, more than 40% of virulence genes were exclusively
present in the clinical isolate collection (Additional file 2:
Figure S2), including genes involved in capsule synthesis
(rmpA) [33], iron transport (iro), phospholipid transport
(mce), regulation and transport (multiple clb genes), and
transcription regulation (kvgA). Multiple iron metabolism-
related and siderophore genes including ybt, irp, and fyuA
were more common (statistical significance level for z-
statistic of logistic regression: p value < 0.05) in clinical
isolates and were incorporated into the chromosome.
The higher number of virulence factors in clinical ver-
sus environmental isolates (Additional file 2: Figure S2),
especially those involved in iron uptake, is suggestive of
hyper-mucoviscous and hyper-virulent strains that may
be more efficient in iron uptake and capsule production
[34]. Some virulence genes were integrated into the
chromosome while others were plasmid-mediated, im-
plying that multiple mechanisms mediate their acquisi-
tion. Some virulence genes were also present in the
genome of other gram-negative bacteria such as E. coli
and Citrobacter koseri, indicating sharing both within
and between species. A full list of the virulence factors
ST Host Isolation site Acquisition* Origin** Infection Status**
16 Human Urine - Clinical -
16 Human Urine - Clinical -
16 Human Sputum - Clinical -
16 Human Blood - Clinical -
17 Human Nose swab Nosocomial - Human carriage
17 Human Stool sample Community - Human carriage
20 Human Urine Community - Human infection
20 Human Bronchial Nosocomial - Human infection
20 Human Ileum Community - Unknown
20 Human Urine Nosocomial - Human infection
20 Human Blood Unknown - Human invasive
17 Human Blood Community - Human invasive
336 Human Urine - Clinical -
336 Human Sputum - Clinical -
336 Human Sputum - Clinical -
336 Human Sputum - Clinical -
17 Human Blood Nosocomial - Human invasive
11 Human Foot Nosocomial - Human infection
11 Human Gastric Nosocomial - Human carriage
11 Human Sputum Nosocomial - Human infection
11 Human Sputum - Clinical -
11 Human Sputum - Clinical -
11 Human Dialysis fluid - Clinical -
11 Human Urine - Clinical -
11 Human Urine - Clinical -
11 Human Urine Nosocomial - Human infection
11 Human Urine Nosocomial - Human infection
11 Human Urine Nosocomial - Human infection
895 Human Canal - Environmental -
895 Human Canal - Environmental -
895 Human Canal - Environmental -
895 Human Canal - Environmental -
895 Human Canal - Environmental -
895 Human Canal - Environmental -
895 Human Pus - Clinical -
11 Human Alveolar Nosocomial - Human infection
Clade  1
5 years
Clade 3
5 years
Fig. 3 Dated trees for clades with a temporal signal. The numbers on the nodes signify the node age (in years), and the bars show 95% confidence
intervals. The symbols * and ** signify the specific features of the Thai and the global collection, respectively
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with their frequencies in clinical and environmental
isolates is provided in Additional file 3.
With the exception of carbapenems, trimethoprim, tige-
cycline, and aminoglycosides, the Thai isolates exhibited
intermediate to high resistance levels to the antibiotics
tested. This finding, along with a correlation between in-
creased minimum inhibitory concentration (MIC) values
and antibiotics with a similar mechanism of action, is indi-
cative of a limited number of effective antibiotics to treat
infections (Additional file 2: Figure S3 and Figure S4). All
isolates were ESBL-positive based on phenotypic testing.
A genome-wide screen for known ESBLs as defined by the
Comprehensive Antibiotic Resistance Database (https://
card.mcmaster.ca/) demonstrated that blaCTX-M-15, blaSHV,
blaVEB, and blaGES accounted for the ESBL phenotypes in
the population. blaGES and blaVEB gene copies were found
exclusively in the environmental hospital sewer isolates
and clinical isolates, respectively. By contrast, blaCTX-M-15
and blaSHV had been sporadically gained by both environ-
mental and clinical isolates. Nineteen isolates (25%) were
found to be multidrug-resistant (resistant to three or more
drug classes), all of which were clinical isolates. Four
isolates were resistant to the carbapenem drugs. Resist-
ance in these isolates was associated with the presence of
plasmid-associated genes encoding carbapenamases, spe-
cifically New Delhi metallo-β-lactamase (NDM) (in two
multidrug-resistant clinical isolates) and GES (in two non-
multidrug-resistant isolates from the hospital sewer).
These genes appear to have been acquired in different
lineages across the phylogenetic tree (Additional file 2:
Figures S5 and S6). Isolation of Klebsiella oxytoca and
Enterobacter cloacae from hospital sewers that harbor
GES has been reported previously [35] and indirectly re-
flects its presence in the hospital population or environ-
ment. Additional file 4 provides a list of β-lactamases and
ESBLs in the collection.
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Fig. 4 Origin, sample type, and isolate features for divergences between a Thai isolate and any other isolate from the Thai or global collection for
non-clade 1 and 3 isolates over the past 50 years. This time corresponds to the formation of clade 1. To obtain the age and the upper and lower
bounds for the 95% confidence interval, we divided the SNP distance by the mean substitution rates of clades 1 and 3 and the means of the
lower and upper values for the 95 confidence intervals of the substitution rates estimated for clades 1 and 3. Each color corresponds to one
country. The symbols ** and * signify the specific features of the Thai and the global collection, respectively. The lower bar plot shows geographical
distance for Thai isolate pairs
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Our results indicated that isolates with an increase in
MIC values and resistant phenotypes occurred in
different lineages throughout the phylogenetic tree
(Additional file 2: Figure S4). However, the MIC values
for β-lactams (especially cephalosporins and aztreonam)
were significantly higher in clinical isolates compared
with environment isolates (Additional file 2: Figure S5).
Consistent with this, clinical isolates carried more copies
of β-lactamase genes (Additional file 2: Figure S6).
Besides the chromosomally encoded blaLEN, blaSHV, and
blaOKP that were present in every isolate, blaOXA,
blaTEM, and blaCTX occurred throughout the tree, and
these genes, in combination with other β-lactamases,
were more common in clinical isolates (Additional file 2:
Figure S6), which is consistent with reports from numer-
ous countries.
No patterns were observed in the presence/absence of
resistance genes for the non-β-lactam antibiotics in en-
vironmental versus hospital isolates (Additional file 2:
Figure S6). The oqx efflux pump gene was present in
every isolate and was not correlated with ciprofloxacin
resistance. However, non-synonymous SNP densities
within DNA topoisomerase IV genes (parE and parC)
and point mutations in D87 DNA gyrase A, as well as in
the E84 DNA topoisomerase IV genes, were exclusively
present in two isolates with high MIC values for cipro-
floxacin. Both mutations occurred in the quinolone
resistance-determining region (QRDR) of gyrA and parC
[36, 37]. These point mutations were only found in clin-
ical isolates, although both have been detected previ-
ously in E. coli isolated from aquatic environments [38].
The aminoglycoside resistance genes were noted to
have been acquired on multiple occasions throughout
the phylogenetic tree. Even though K. pneumoniae is
reported to be intrinsically resistant to tetracyclines,
the acquisition of further copies of tetracycline resist-
ance genes occurred across the tree in both clinical and
environmental isolates (Additional file 2: Figure S6).
Discussion
In this study we investigated the epidemiology of K.
pneumoniae in a defined geographic area that included a
general hospital and surrounding canals and farms. Our
findings support the suggestion that clinical K. pneumo-
niae have evolved mechanisms to better adapt to sur-
vival in the clinical setting. Virulence factors were more
frequent in clinical isolates and had been acquired on
more than one occasion. This indicates the selection and
dissemination of virulent strains in hospitals. Further-
more, the higher number of β-lactam resistance genes in
clinical isolates together with higher absolute MIC
values for some β-lactams for K. pneumoniae of clinical
origin can be attributed to higher exposure to antibi-
otics, as proposed previously [39]. Given our finding of
recent divergence events between clinical and environ-
mental isolates, our results suggest that the selective
pressure imposed upon clinical isolates is sufficient to
result in significant changes in the genome of clinical
isolates within a few decades. It has been reported
previously that the prevalence of antibiotic resistance
of food-borne isolates is higher for meat-source K.
pneumoniae isolates than for human clinical isolates
[16]. However, due to the lack of sufficient data about
the strength of selective antibiotic pressure in food-
animal production versus hospitals, it is not possible
to draw a definitive conclusion about antibiotic use
and resistance [16].
The detection of carbapenem-resistant isolates in pre-
treated hospital wastewater reiterates the importance of
the treatment of hospital wastewater prior to release into
the environment [40, 41]. Our study also highlights the
role of environmental water as a potential reservoir for
K. pneumoniae, where antibiotic resistant isolates may
emerge. Antibiotic resistance genes present in environ-
mental isolates were present in the founder lineage in
some cases, for instance, in isolates in the mixed envir-
onmental and clinical clade 3 (Fig. 3 and Additional file
2: Figure S3), which is consistent with contamination of
such reservoirs. Resistance was also noted to have
emerged in some environmental lineages against various
antibiotics, for instance, ertapenem, cefoxitin, amikacin,
and amoxicillin-clavulanic acid in sewage water isolates
(Additional file 2: Figure S3), which presumably arises in
response to antibiotics in environmental wastewater, as
reported previously [42, 43]. Several studies have shown
the presence of highly antibiotic-resistant bacteria and
resistance genes in sewage released into aquatic environ-
ments [42, 44–46]. In line with these findings, our re-
sults suggest that the release of untreated hospital
sewage may play a role in the environmental emergence
and spread of multiresistant pathogenic bacteria, and
that wastewater (including hospital waste) warrants
treatment to eliminate these organisms prior to release.
This may be of particular importance in low-income
rural areas and countries, where people are in greater
contact with wastewater and may consume contaminated
food and water containing high levels of antibiotic-
resistant bacteria. Of note, wastewater is treated prior to
release from Bhuddhasothorn Hospital, and no ESBL-
positive K. pneumoniae were isolated from post-treated
waste.
Conclusions
In this study the availability of epidemiologic informa-
tion and the high resolution of whole genome sequen-
cing allowed us to discover epidemiologic links between
clinical and non-clinical K. pneumoniae. Limitations of
the collection were the sparseness of the environmental
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collection and the lack of non-ESBL-producing strains.
This happened because our isolates were selected using
media that were selective for ESBL production. The
isolation of K. pneumoniae from highly contaminated
samples is challenging without the use of selective cul-
ture, but our approach means that the environmental
collection was biased towards clinically important iso-
lates, i.e., ESBL-producing strains. This facilitated the
identification of distinct genomic patterns relating to the
distribution of antimicrobial resistance and virulence
factor genes in clinical isolates, but the inclusion of
non-ESBL isolates, particularly from environmental
sites, is required to obtain a broader assessment of clin-
ical and non-clinical populations. The inclusion of sus-
ceptible isolates from the environment and hospital
may reduce the difference in antibiotic resistance ob-
served here between clinical and environmental iso-
lates, although the effect on virulence gene pattern is
difficult to predict. Future studies based on larger and
deeper collections will be required to gain a detailed
understanding of global transmission of K. pneumoniae
at different geographical scales.
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